Cargando…

The Multifaceted Role and Utility of MicroRNAs in Indolent B-Cell Non-Hodgkin Lymphomas

Normal B-cell development is a tightly regulated complex procedure, the deregulation of which can lead to lymphomagenesis. One common group of blood cancers is the B-cell non-Hodgkin lymphomas (NHLs), which can be categorized according to the proliferation and spread rate of cancer cells into indole...

Descripción completa

Detalles Bibliográficos
Autores principales:	Artemaki, Pinelopi I., Letsos, Petros A., Zoupa, Ioanna C., Katsaraki, Katerina, Karousi, Paraskevi, Papageorgiou, Sotirios G., Pappa, Vasiliki, Scorilas, Andreas, Kontos, Christos K.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8064455/ https://www.ncbi.nlm.nih.gov/pubmed/33806113 http://dx.doi.org/10.3390/biomedicines9040333

Ejemplares similares

MicroRNAs: Tiny Regulators of Gene Expression with Pivotal Roles in Normal B-Cell Development and B-Cell Chronic Lymphocytic Leukemia
por: Katsaraki, Katerina, et al.
Publicado: (2021)

Circular RNAs: Emerging Regulators of the Major Signaling Pathways Involved in Cancer Progression
por: Papatsirou, Maria, et al.
Publicado: (2021)

Novel circular RNAs of the apoptosis‐related BAX and BCL2L12 genes identified in a chronic lymphocytic leukemia cell line using nanopore sequencing
por: Kontos, Christos K., et al.
Publicado: (2023)

Identification of Two Novel Circular RNAs Deriving from BCL2L12 and Investigation of Their Potential Value as a Molecular Signature in Colorectal Cancer
por: Karousi, Paraskevi, et al.
Publicado: (2020)

Circular RNAs: A New Piece in the Colorectal Cancer Puzzle
por: Artemaki, Pinelopi I., et al.
Publicado: (2020)

Editorial for the Special Issue “Molecular Biomarkers in Colorectal Adenocarcinoma”
por: Artemaki, Pinelopi I., et al.
Publicado: (2021)

Alternative Splicing in Human Physiology and Disease
por: Artemaki, Pinelopi I., et al.
Publicado: (2022)

Identification of Novel Circular RNAs of the Human Protein Arginine Methyltransferase 1 (PRMT1) Gene, Expressed in Breast Cancer Cells
por: Papatsirou, Maria, et al.
Publicado: (2022)

High Expression of a tRNA(Pro) Derivative Associates with Poor Survival and Independently Predicts Colorectal Cancer Recurrence
por: Tsiakanikas, Panagiotis, et al.
Publicado: (2022)

Multiple Myeloma Bone Disease: Implication of MicroRNAs in Its Molecular Background
por: Papanota, Aristea-Maria, et al.
Publicado: (2021)

Next-generation sequencing reveals altered gene expression and enriched pathways in triple-negative breast cancer cells treated with oleuropein and oleocanthal
por: Karousi, Paraskevi, et al.
Publicado: (2023)

MicroRNA-155-5p Overexpression in Peripheral Blood Mononuclear Cells of Chronic Lymphocytic Leukemia Patients Is a Novel, Independent Molecular Biomarker of Poor Prognosis
por: Papageorgiou, Sotirios G., et al.
Publicado: (2017)

Discovery and Comprehensive Characterization of Novel Circular RNAs of the Apoptosis-Related BOK Gene in Human Ovarian and Prostate Cancer Cells, Using Nanopore Sequencing
por: Kontos, Christos K., et al.
Publicado: (2023)

tRNA Derivatives in Multiple Myeloma: Investigation of the Potential Value of a tRNA-Derived Molecular Signature
por: Karousi, Paraskevi, et al.
Publicado: (2021)

Revised Exon Structure of l-DOPA Decarboxylase (DDC) Reveals Novel Splice Variants Associated with Colorectal Cancer Progression
por: Artemaki, Pinelopi I., et al.
Publicado: (2020)

Multiple osteolytic lesions due to Double-Expressor Primary non-Hodgkin Lymphoma of the Bone
por: Papageorgiou, Sotirios, et al.
Publicado: (2020)

A Cancer-Related microRNA Signature Shows Biomarker Utility in Multiple Myeloma
por: Papanota, Aristea-Maria, et al.
Publicado: (2021)

3′-tRF-Cys(GCA) overexpression in HEK-293 cells alters the global expression profile and modulates cellular processes and pathways
por: Karousi, Paraskevi, et al.
Publicado: (2023)

Immunotherapy in indolent Non-Hodgkin's Lymphoma
por: Amhaz, Ghid, et al.
Publicado: (2022)

High mRNA Expression Levels of Heat Shock Protein Family B Member 2 (HSPB2) Are Associated with Breast Cancer Patients’ Relapse and Poor Survival
por: Sklirou, Aimilia D., et al.
Publicado: (2022)

The role of bendamustine in the treatment of indolent non-Hodgkin lymphoma
por: Aldoss, Ibrahim T, et al.
Publicado: (2009)

Novel Therapies for Follicular Lymphoma and Other Indolent Non-Hodgkin Lymphomas
por: Leslie, Lori A.
Publicado: (2021)

The Role of mTOR Inhibitors for the Treatment of B-Cell Lymphomas
por: Argyriou, Pinelopi, et al.
Publicado: (2012)

Bendamustine: Safety and Efficacy in the Management of Indolent Non-Hodgkins Lymphoma
por: Tageja, Nishant
Publicado: (2011)

Bendamustine HCL for the treatment of relapsed indolent non-Hodgkin’s lymphoma
por: Weide, Rudolf
Publicado: (2008)

Role of antibody-based therapy in indolent non-Hodgkin's lymphoma
por: Willard, Patrick, et al.
Publicado: (2021)

Zanubrutinib monotherapy in relapsed/refractory indolent non-Hodgkin lymphoma
por: Phillips, Tycel, et al.
Publicado: (2022)

Therapeutic Activity of Lenalidomide in Mantle Cell Lymphoma and Indolent Non-Hodgkin's Lymphomas
por: Gunnellini, Marco, et al.
Publicado: (2012)

Targeted Agents in the Treatment of Indolent B-Cell Non-Hodgkin Lymphomas
por: Minson, Adrian, et al.
Publicado: (2022)

Increased plasma endostatin and GDF15 in indolent non-Hodgkin lymphoma
por: Hidman, Josefin, et al.
Publicado: (2023)

Brentuximab vedotin in relapsed/refractory Hodgkin lymphoma. The Hellenic experience
por: Angelopoulou, Maria K., et al.
Publicado: (2017)

An open‐label phase 2 trial of entospletinib in indolent non‐Hodgkin lymphoma and mantle cell lymphoma
por: Andorsky, David J., et al.
Publicado: (2018)

Comparison of CT, PET, and PET/CT for Staging of Patients with Indolent Non-Hodgkin’s Lymphoma
por: Fueger, Barbara J., et al.
Publicado: (2009)

Idelalisib for the treatment of indolent non-Hodgkin lymphoma: a review of its clinical potential
por: Barrientos, Jacqueline C
Publicado: (2016)

Effectiveness and tolerability of radiotherapy for patients with indolent non-Hodgkin’s lymphoma: a monocenter analysis
por: Hadi, I., et al.
Publicado: (2021)

Factors Impacting Treatment Decision Making in Older Adults With Indolent Non-Hodgkin Lymphoma
por: Trevino, Kelly, et al.
Publicado: (2021)

PB1740: THE COMBINATION OF PONATINIB PLUS CHEMOTHERAPY UPFRONT ACHIEVES DURABLE COMPLETE MOLECULAR REMISSIONS IN ADULTS PATIENTS WITH PHILADELPHIA CHROMOSOME-POSITIVE (PH+) ACUTE LYMPHOBLASTIC LEUKEMIA.
por: Sotirios, Papageorgiou, et al.
Publicado: (2023)

Rhodotorula mucilaginosa associacted meningitis: A subacute entity with high mortality. Case report and review
por: Tsiodras, Sotirios, et al.
Publicado: (2014)

An evaluation of the potential for drug–drug interactions between bendamustine and rituximab in indolent non-Hodgkin lymphoma and mantle cell lymphoma
por: Darwish, Mona, et al.
Publicado: (2014)

Plasmablastic Lymphoma in an Immunocompetent Patient with MDS/MPN with Ring Sideroblasts and Thrombocytosis—A Case Report
por: Bouchla, Anthi, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_erqogmb6ing0m3cb6a49e7t3ms